Long-term study on immune thrombocytopenia
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study follows patients with immune thrombocytopenia (ITP) to learn more about the condition over time. ITP is a disorder where the immune system attacks platelets, which help blood clot. The goal is to better understand the disease and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ITP (immune thrombocytopenia).
- You have been treated at Peking University People's Hospital since January 1, 2005.
- You do not have a condition like a severe psychiatric disorder that could make follow-up data unreliable.
- You are considered suitable for the study by the investigators.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both immune thrombocytopenia (ITP) and a recent stroke. It aims to learn more about how these conditions interact and what treatments work best.
This study looks back at medical records of people with newly diagnosed or persistent ITP (lasting up to 12 months) to understand how the condition is treated in real life. Anyone who received standard ITP treatments or none at all may be included.
This trial tests an IV medicine called V-IMMUNE® for people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The study aims to see if V-IMMUNE® can safely raise platelet counts in both children and adults.
This study follows children aged 6-17 with immune thrombocytopenia (ITP) over time to better understand the condition and how it changes. It aims to learn more about ITP in children to improve future care.
This study looks at how people with immune thrombocytopenia (ITP) are doing after having their spleen removed. By tracking your health over time, researchers hope to learn more about the long-term results of this treatment.
This study collects data from people with immune thrombocytopenia (a condition where the immune system destroys platelets, causing low blood counts). It aims to better understand and track the disease over time.
Hear when a new Immune Thrombocytopenia (ITP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.